Changes in central dopaminergic systems and morphine reward by prenatal and neonatal exposure to bisphenol-A in mice: Evidence for the importance of exposure period

Addiction Biology

Volumn 12, Issue 2, 2007, Pages 167-172

  Narita, Minoru ^a   Miyagawa, Kazuya ^a   Mizuo, Keisuke ^a   Yoshida, Takuya ^a   Suzuki, Tsutomu ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Bisphenol A; Endocrine disruptor; Exposure periods; Hyperlocomotion; Morphine; Rewarding effect

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; DOPAMINE; DOPAMINE RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; MORPHINE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN MATURATION; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; FEMALE; FOREBRAIN; LACTATION; LIMBIC CORTEX; LOCOMOTION; MOUSE; NEUROTOXICITY; NEWBORN; NONHUMAN; PERINATAL PERIOD; PRENATAL EXPOSURE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REWARD;

ANIMALS; ANIMALS, NEWBORN; BRAIN; CHOICE BEHAVIOR; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FEMALE; GTP-BINDING PROTEINS; LIMBIC SYSTEM; MICE; MICE, INBRED STRAINS; MORPHINE; MOTIVATION; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; PHENOLS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROSENCEPHALON; RECEPTORS, DOPAMINE; REWARD;

EID: 34248545407     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2007.00048.x     Document Type: Article

References (30)

1. Ashby J, Tinwell H (1998) Uterotrophic activity of bisphenol A in the immature rat. Environ Health Perspect 106 : 719 720.
2. BPA Safety Committee of Japanese Manufactures (2002) [www document] http://www.bisphenol-a.gr.jp (accessed on 31 March 2007).
3. Cagen SZ, Waechter JM Jr, Dimond SS, Breslin WJ, Butala JH, Jekat FW, Joiner RL, Shiotsuka RN, Veenstra GE, Harris LR (1999) Normal reproductive organ development in CF-1 mice following prenatal exposure to bisphenol A. Toxicol Sci 50 : 36 44.
4. De Boer P, Enrico P, Wright J, Wise LD, Timmerman W, Moor E, Dijkstra D, Wikstrom HV, Westerink BH (1997) Characterization of the effect of dopamine D3 receptor stimulation on locomotion and striatal dopamine levels. Brain Res 758 : 83 91.
5. Farabollini F, Porrini S, Della Seta D, Bianchi F, Dessi-Fulgheri F (2002) Effects of perinatal exposure to bisphenol A on sociosexual behavior of female and male rats. Environ Health Perspect 110 : 409 414.
6. Funada M, Suzuki T, Misawa M (1994) The role of dopamine D1-receptors in morphine-induced hyperlocomotion in mice. Neurosci Lett 169 : 1 4.
7. Gould JC, Leonard LS, Maness SC, Wagner BL, Conner K, Zacharewski T, Safe S, McDonnell DP, Gaido KW (1998) Bisphenol A interacts with the estrogen receptor alpha in a distinct manner from estradiol. Mol Cell Endocrinol 142 : 203 214.
8. Howdeshell KL, Hotchkiss AK, Thayer KA, Vandenbergh JG, vom Saal FS (1999) Exposure to bisphenol A advances puberty. Nature 401 : 763 764.
9. Koob GF (1992) Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13 : 177 184.
10. Krishnan AV, Stathis P, Permuth SF, Tokes L, Feldman D (1993) Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology 132 : 2279 2286.
11. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139 : 4252 4263.
12. Maldonado R, Dauge V, Feger J, Roques BP (1990) Chronic blockade of D2 but not D1 dopamine receptors facilitates behavioural responses to endogenous enkephalins, protected by kelatorphan, administered in the accumbens in rats. Neuropharmacology 29 : 215 223.
13. Mizuo K, Narita M, Miyagawa K, Okuno E, Suzuki T (2004a) Prenatal and neonatal exposure to bisphenol-A affects the morphine-induced rewarding effect and hyperlocomotion in mice. Neurosci Lett 356 : 95 98.
14. Mizuo K, Narita M, Yoshida T, Suzuki T (2004b) Functional changes in dopamine D3 receptors by prenatal and neonatal exposure to an endocrine disruptor bisphenol-A in mice. Addict Biol 9 : 19 25.
15. Narita M, Funada M, Suzuki T (2001) Regulations of opioid dependence by opioid receptor types. Pharmacol Ther 89 : 1 15.
16. Narita M, Mizuo K, Mizoguchi H, Sakata M, Narita M, Tseng LF, Suzuki T (2003) Molecular evidence for the functional role of dopamine D3 receptor in the morphine-induced rewarding effect and hyperlocomotion. J Neurosci 23 : 1006 1012.
17. Narita M, Takahashi Y, Takamori K, Funada M, Suzuki T, Misawa M, Nagase H (1993) Effects of kappa-agonist on the antinociception and locomotor enhancing action induced by morphine in mice. Jpn J Pharmacol 62 : 15 24.
18. Phillips AG, LePiane FG, Fibiger HG (1983) Dopaminergic mediation of reward produced by direct injection of enkephalin into the ventral tegmental area of rat. Life Sci 33 : 2505 2511.
19. Seiwa C, Nakahara J, Komiyama T, Katsu Y, Iguchi T, Asou H (2004) Bisphenol A exerts thyroid-hormone-like effects on mouse oligodendrocyte precursor cells. Neuroendocrinology 80 : 21 30.
20. Shippenberg TS, Bals-Kubik R, Herz A (1993) Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine and D-1 versus D-2 dopamine receptors. J Pharmacol Exp Ther 265 : 53 59.
21. Sokoloff P, Giros B, Martres M-P, Bouthnet ML, Schwartz JC (1990) Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347 : 146 151.
22. Staples CA, Dorn PB, Klecka GM, O'Block ST, Harris LR (1998) A review of the environmental fate, effects, and exposures of bisphenol A. Chemosphere 36 : 2149 2173.
23. Stinus L, Nadaud D, Jauregui J, Kelley AE (1986) Chronic treatment with five different neuroleptics elicits behavioral supersensitivity to opiate infusion into the nucleus accumbens. Biol Psychiatry 21 : 34 48.
24. Suzuki T (1996) Conditioned place preference in mice. Methods Find Exp Clin Pharmacol 18 : 75 83.
25. Suzuki T, Funada M, Narita M, Misawa M, Nagase H (1991) Pertussis toxin abolishes mu- and delta-opioid agonist-induced place preference. Eur J Pharmacol 205 : 85 88.
26. Suzuki T, Funada M, Narita M, Misawa M, Nagase H (1993) Morphine-induced place preference in the CXBK mouse: characteristics of m opioid receptor subtypes. Brain Res 602 : 45 52.
27. Suzuki T, Maeda J, Funada M, Misawa M (1995) The D3-receptor agonist (+/-)-7-hydroxy-N,N-di-npropyl-2-aminotetralin (7-OH-DPAT) attenuates morphine-induced hyperlocomotion in mice. Neurosci Lett 187 : 45 48.
28. Suzuki T, Mizuo K, Nakazawa H, Funae Y, Fushiki S, Fukushima S, Shirai T, Narita M (2003) Prenatal and neonatal exposure to bisphenol-A enhances the central dopamine D1 receptor-mediated action in mice: enhancement of the methamphetamine-induced abuse state. Neuroscience 117 : 639 644.
29. Temple S (2001) The development of neural stem cells. Nature 414 : 112 117.
30. Wise RA, Rompre PP (1989) Brain dopamine and reward. Annu Rev Psychol 40 : 191 225.